<?xml version="1.0" encoding="utf-8" standalone="no"?>    
<rss version="2.0">    
      <channel>  
            <title>AllInOneNews: leukemia</title>  
            <image><title>AllInOneNews</title>    
               <url>http://www.allinonenews.com/images/title3.gif</url></image>      
            <link>http://www.allinonenews.com/</link>   
            <description>--powered by Webscaler's technology</description>   
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3ymH]]></guid>  
             <title><![CDATA[Over-Expression Of Gene Regulator Spurs Development Of Leukemia In Babies With Down Syndrome]]></title>  
             <link><![CDATA[http://mnt.to/f/3ymH]]></link>  
             <description><![CDATA[[Medical News Today, UK] Between 5 and 10 percent of babies with Down syndrome develop a transient form of leukemia that usually resolves on its own. However, for reasons that haven't been clear, 20 to 30 percent of these babies progress to a more serious leukemia known as Down syndrome acute megakaryoblastic leukemia (DS-AMKL), which affects the blood progenitor cells that form red blood cells and platelets...]]></description>  
             <pubDate>Wed Mar 03 02:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://biz.yahoo.com/bw/100311/20100311005137.html]]></guid>  
             <title><![CDATA[BioSante Announces Positive Leukemia Vaccine Results]]></title>  
             <link><![CDATA[http://biz.yahoo.com/bw/100311/20100311005137.html]]></link>  
             <description><![CDATA[[Business Wire] LINCOLNSHIRE, Ill.----BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia patients taking the drug Gleevec .]]></description>  
             <pubDate>Thu Mar 11 06:55:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3yKv]]></guid>  
             <title><![CDATA[2010 Recipient Of Minority Scholar Award Will Conduct Clinical Research On Leukemia]]></title>  
             <link><![CDATA[http://mnt.to/f/3yKv]]></link>  
             <description><![CDATA[[Medical News Today, UK] Alison Walker, MD, has been selected to receive the ASH-AMFDP Award, and will begin her research in acute myeloid leukemia in July of this year...]]></description>  
             <pubDate>Wed Mar 10 10:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://biz.yahoo.com/ap/100219/us_novartis_fda.html]]></guid>  
             <title><![CDATA[Novartis leukemia drug gets faster FDA review]]></title>  
             <link><![CDATA[http://biz.yahoo.com/ap/100219/us_novartis_fda.html]]></link>  
             <description><![CDATA[[Associated Press] Novartis AG said Friday its leukemia drug candidate Tasigna received priority review by the Food and Drug Administration.]]></description>  
             <pubDate>Fri Feb 19 10:01:26 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://www.marketwatch.com/News/Story/Story.aspx?guid=36EF4705-D814-46BA-9337-FF9A928D00F1&siteid=yhoof2]]></guid>  
             <title><![CDATA[BioSante rallies on study; drug stocks slip]]></title>  
             <link><![CDATA[http://www.marketwatch.com/News/Story/Story.aspx?guid=36EF4705-D814-46BA-9337-FF9A928D00F1&siteid=yhoof2]]></link>  
             <description><![CDATA[[at MarketWatch] Shares of BioSante Pharmaceuticals Inc. soar in early action, powered by a study that shows its GVAX Leukemia vaccine appeared to be effective in battling chronic myeloid leukemia, or CML.]]></description>  
             <pubDate>Thu Mar 11 02:46:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://www.marketwatch.com/news/story/biosante-rallies-study-drug-stocks/story.aspx?guid=%7B36EF4705%2DD814%2D46BA%2D9337%2DFF9A928D00F1%7D&siteid=yhoof]]></guid>  
             <title><![CDATA[Biotech Stocks: BioSante rallies on study; drug stocks slip]]></title>  
             <link><![CDATA[http://www.marketwatch.com/news/story/biosante-rallies-study-drug-stocks/story.aspx?guid=%7B36EF4705%2DD814%2D46BA%2D9337%2DFF9A928D00F1%7D&siteid=yhoof]]></link>  
             <description><![CDATA[[at MarketWatch] Shares of BioSante Pharmaceuticals Inc. soar in early action, powered by a study that shows its GVAX Leukemia vaccine appeared to be effective in battling chronic myeloid leukemia, or CML.]]></description>  
             <pubDate>Thu Mar 11 09:46:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3xSH]]></guid>  
             <title><![CDATA[Doubling Of Childhood Leukemia Rates In Southern Iraq Confirmed By International Study]]></title>  
             <link><![CDATA[http://mnt.to/f/3xSH]]></link>  
             <description><![CDATA[[Medical News Today, UK] Childhood leukemia rates have more than doubled over the last 15 years in the southern Iraq province of Basrah, according to the study, "Trends in Childhood Leukaemia in Basrah, Iraq (1993-2007), published in the American Journal of Public Health...]]></description>  
             <pubDate>Mon Feb 22 02:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3ykQ]]></guid>  
             <title><![CDATA[Overcoming Multidrug Resistance In Acute Lymphoblastic Leukemia Cells]]></title>  
             <link><![CDATA[http://mnt.to/f/3ykQ]]></link>  
             <description><![CDATA[[Medical News Today, UK] Acute lymphoblastic leukemia (ALL) most commonly affects children, in whom there is an overall cure rate of 85%. A strong predictor of poor outcome is resistance to chemotherapy with glucocorticoids. Such resistance is caused, at least in part, by an inability of the leukemic cells to die by a process known as mitochondrial apoptosis...]]></description>  
             <pubDate>Tue Mar 02 07:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3yzc]]></guid>  
             <title><![CDATA[Key Cause Of Chronic Leukemia Progression Identified By Study]]></title>  
             <link><![CDATA[http://mnt.to/f/3yzc]]></link>  
             <description><![CDATA[[Medical News Today, UK] Researchers have discovered a key reason why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis. The study, led by cancer researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J...]]></description>  
             <pubDate>Mon Mar 08 02:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3ygC]]></guid>  
             <title><![CDATA[New Cancer Treatment Gives Hope To Lymphoma And Leukemia Patients]]></title>  
             <link><![CDATA[http://mnt.to/f/3ygC]]></link>  
             <description><![CDATA[[Medical News Today, UK] Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia. PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Piper Cancer Center in collaboration with the Clinical Division of the Translational Genomics Research Institute (TGen)...]]></description>  
             <pubDate>Mon Mar 01 04:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3ydL]]></guid>  
             <title><![CDATA[Cells Of Aggressive Leukemia Hijack Normal Protein To Grow]]></title>  
             <link><![CDATA[http://mnt.to/f/3ydL]]></link>  
             <description><![CDATA[[Medical News Today, UK] Researchers have found that one particularly aggressive type of blood cancer, mixed lineage leukemia (MLL), has an unusual way to keep the molecular motors running. The cancer cells rely on the normal version of an associated protein to stay alive.  MLL happens when a piece of chromosome 11 breaks off at the normal MLL-associated gene...]]></description>  
             <pubDate>Sun Feb 28 02:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3xV6]]></guid>  
             <title><![CDATA[Novartis Drug Tasigna  Receives FDA Priority Review For Newly Diagnosed Patients With Early-stage Chronic Myeloid Leukemia]]></title>  
             <link><![CDATA[http://mnt.to/f/3xV6]]></link>  
             <description><![CDATA[[Medical News Today, UK] Novartis announced that Tasigna&#174; (nilotinib) has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase...]]></description>  
             <pubDate>Sat Feb 20 04:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3xTy]]></guid>  
             <title><![CDATA[Novartis Drug Tasigna(R) Receives FDA Priority Review For Newly Diagnosed Patients With Early-Stage Chronic Myeloid Leukemia]]></title>  
             <link><![CDATA[http://mnt.to/f/3xTy]]></link>  
             <description><![CDATA[[Medical News Today, UK] Novartis announced that Tasigna&#174; (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase...]]></description>  
             <pubDate>Sat Feb 20 03:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feeds.latimes.com/~r/latimes/sports/~3/WvR7oau7J90/la-sp-simers23-2010feb23,0,1837126.column]]></guid>  
             <title><![CDATA[        Carew, the great hitter, is coming to bat for others]]></title>  
             <link><![CDATA[http://feeds.latimes.com/~r/latimes/sports/~3/WvR7oau7J90/la-sp-simers23-2010feb23,0,1837126.column]]></link>  
             <description><![CDATA[[Los Angeles Times] Fourteen years after losing his daughter to leukemia, the Hall of Famer raises funds for pediatric cancer research. Explaining his transition from standoffish to obliging, he says: 'I grew up.'                          Fourteen years after losing his daughter to leukemia, the Hall of Famer raises funds for pediatric cancer research. Explaining his transition from standoffish to obliging, he says: 'I grew up.']]></description>  
             <pubDate>Mon Feb 22 21:45:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3y9P]]></guid>  
             <title><![CDATA[Sunesis Poised For Phase 3 Trial Of Voreloxin In Acute Myeloid Leukemia After Completing Formal End-of-Phase 2 Meetings With FDA]]></title>  
             <link><![CDATA[http://mnt.to/f/3y9P]]></link>  
             <description><![CDATA[[Medical News Today, UK] Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) related to its lead compound, voreloxin, in acute myeloid leukemia (AML). Sunesis has received feedback and guidance from the FDA in response to proposed plans for further development of voreloxin in the treatment of AML...]]></description>  
             <pubDate>Fri Feb 26 04:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://usatoday.com/communities/theoval/post/2010/03/obama-letter-writer-now-has-luekemia-and-no-insurance/1?imw=Y]]></guid>  
             <title><![CDATA[Obama letter writer has leukemia and no insurance - The Oval: Tracking the Obama presidency]]></title>  
             <link><![CDATA[http://usatoday.com/communities/theoval/post/2010/03/obama-letter-writer-now-has-luekemia-and-no-insurance/1?imw=Y]]></link>  
             <description><![CDATA[[USATODAY.com] ]]></description>  
             <pubDate>Mon Mar 15 17:30:17 CDT 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://biz.yahoo.com/bw/100301/20100301005338.html]]></guid>  
             <title><![CDATA[ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia]]></title>  
             <link><![CDATA[http://biz.yahoo.com/bw/100301/20100301005338.html]]></link>  
             <description><![CDATA[[Business Wire] ]]></description>  
             <pubDate>Mon Mar 01 06:35:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://rss.cnn.com/~r/rss/cnn_health/~3/OISmNTM96zM/index.html]]></guid>  
             <title><![CDATA[Cord blood stem cells help minorities]]></title>  
             <link><![CDATA[http://rss.cnn.com/~r/rss/cnn_health/~3/OISmNTM96zM/index.html]]></link>  
             <description><![CDATA[[CNN.com International] Diana Tirpak was so sure her leukemia was going to kill her, she bought a suit for her husband, Jake, to wear at her funeral.    ]]></description>  
             <pubDate>Mon Mar 01 21:09:06 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://edition.cnn.com/2010/HEALTH/03/01/cord.blood.marrow.minorities/index.html?eref=edition]]></guid>  
             <title><![CDATA[Cord blood stem cells saving lives]]></title>  
             <link><![CDATA[http://edition.cnn.com/2010/HEALTH/03/01/cord.blood.marrow.minorities/index.html?eref=edition]]></link>  
             <description><![CDATA[[CNN.com International] Diana Tirpak was so sure her leukemia was going to kill her, she bought a suit for her husband, Jake, to wear at her funeral.]]></description>  
             <pubDate>Mon Mar 01 21:09:06 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://rss.cnn.com/~r/rss/cnn_latest/~3/F0Wp3__P3sw/index.html]]></guid>  
             <title><![CDATA[Cord blood stem cells help meet minority marrow needs]]></title>  
             <link><![CDATA[http://rss.cnn.com/~r/rss/cnn_latest/~3/F0Wp3__P3sw/index.html]]></link>  
             <description><![CDATA[[CNN.com International] Diana Tirpak was so sure her leukemia was going to kill her, she bought a suit for her husband, Jake, to wear at her funeral.    ]]></description>  
             <pubDate>Mon Mar 01 21:09:06 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://www.cbc.ca/arts/story/2010/02/18/sp-henderson-cancer.html]]></guid>  
             <title><![CDATA[Canadian hockey hero Henderson has cancer]]></title>  
             <link><![CDATA[http://www.cbc.ca/arts/story/2010/02/18/sp-henderson-cancer.html]]></link>  
             <description><![CDATA[[The Canadian Broadcasting Corporation] Canadian hockey hero Paul Henderson revealed he is battling cancer - a form of leukemia.]]></description>  
             <pubDate>Thu Feb 18 20:26:53 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feeds.nytimes.com/click.phdo?i=c369406270052bfd6eb55b29aa1ce833]]></guid>  
             <title><![CDATA[Obama Takes His Pitch for Health Care Overhaul to Ohio]]></title>  
             <link><![CDATA[http://feeds.nytimes.com/click.phdo?i=c369406270052bfd6eb55b29aa1ce833]]></link>  
             <description><![CDATA[[The New York Times] At a seniors' center in Ohio, President Obama talked about a cleaning woman who had dropped her costly insurance plan, only to discover she had leukemia.]]></description>  
             <pubDate>Tue Mar 16 00:36:33 CDT 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feeds.bizjournals.com/~r/vertical_39/~3/N_CdRLvGtxA/daily23.html]]></guid>  
             <title><![CDATA[Mpls.St.Paul magazine editor Anderson dies]]></title>  
             <link><![CDATA[http://feeds.bizjournals.com/~r/vertical_39/~3/N_CdRLvGtxA/daily23.html]]></link>  
             <description><![CDATA[[Bizjournals] Brian Anderson, the editor of Mpls.St.Paul magazine for the past 33 years, died Tuesday after struggling with a rare form of leukemia. He was 65.   ]]></description>  
             <pubDate>Wed Mar 17 09:06:36 CDT 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feeds.bizjournals.com/~r/vertical_44/~3/decU7Y5hjzE/daily11.html]]></guid>  
             <title><![CDATA[FORMA teams to develop lymphoma drugs]]></title>  
             <link><![CDATA[http://feeds.bizjournals.com/~r/vertical_44/~3/decU7Y5hjzE/daily11.html]]></link>  
             <description><![CDATA[[Bizjournals] The Leukemia &amp; Lymphoma Society and FORMA Therapeutics Inc. have partnered to develop drug candidates targeting lymphoma.   ]]></description>  
             <pubDate>Mon Mar 15 12:56:49 CDT 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b39DB8CDF-C07A-4FD8-BAD2-345CB21CA0ED%7d&siteid=yhoof2]]></guid>  
             <title><![CDATA[BioSante soars on study; drug stocks slip]]></title>  
             <link><![CDATA[http://www.marketwatch.com/News/Story/Story.aspx?guid=%7b39DB8CDF-C07A-4FD8-BAD2-345CB21CA0ED%7d&siteid=yhoof2]]></link>  
             <description><![CDATA[[at MarketWatch] Shares of BioSante Pharmaceuticals Inc. soared 16% in early action Thursday, powered by a study that showed its GVAX vaccine appeared to be effective in batting chronic myeloid leukemia, or CML.]]></description>  
             <pubDate>Thu Mar 11 09:11:41 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://biz.yahoo.com/ap/100311/us_biosante_gvax_study.html]]></guid>  
             <title><![CDATA[BioSante cites positive GVAX study, shares rise]]></title>  
             <link><![CDATA[http://biz.yahoo.com/ap/100311/us_biosante_gvax_study.html]]></link>  
             <description><![CDATA[[Associated Press] BioSante Pharmaceuticals said Thursday that its GVAX cancer treatment led to a reduction of cancer cells in leukemia patients who had been taking the cancer drug Gleevec for at least one year.]]></description>  
             <pubDate>Thu Mar 11 11:56:35 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://biz.yahoo.com/ap/100301/us_ariad_pharmaceuticals_orphan_drug_status.html]]></guid>  
             <title><![CDATA[Ariad cancer treatment gets 'orphan drug' status]]></title>  
             <link><![CDATA[http://biz.yahoo.com/ap/100301/us_ariad_pharmaceuticals_orphan_drug_status.html]]></link>  
             <description><![CDATA[[Associated Press] Drug developer Ariad Pharmaceuticals Inc. said Monday that U.S. and European regulators have given "orphan drug" status for a potential leukemia treatment it is developing.]]></description>  
             <pubDate>Mon Mar 01 08:09:23 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://news.yahoo.com/s/hsn/20100227/hl_hsn/virusunlikelytocausechronicfatiguesyndrome]]></guid>  
             <title><![CDATA[Virus Unlikely to Cause Chronic Fatigue Syndrome]]></title>  
             <link><![CDATA[http://news.yahoo.com/s/hsn/20100227/hl_hsn/virusunlikelytocausechronicfatiguesyndrome]]></link>  
             <description><![CDATA[[HealthDay] THURSDAY, Feb. 25 (HealthDay News) -- A new study adds to evidence that chronic fatigue syndrome doesn't have anything to do with xenotropic murine leukemia virus-related virus (XMRV), but the researchers point out that there's a caveat regarding American patients.]]></description>  
             <pubDate>Fri Feb 26 22:50:29 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feeds.washingtonpost.com/click.phdo]]></guid>  
             <title><![CDATA[Joseph Naughton, M.T. Symington, Alfonso Tarabochia, James Thompson, Harlan Westover, Nancy Martin, Helen Roumel die]]></title>  
             <link><![CDATA[http://feeds.washingtonpost.com/click.phdo]]></link>  
             <description><![CDATA[[The Washington Post] Joseph D. Naughton, 76, who was the chief of the computer center branch at the National Institutes of Health in Bethesda, died Feb. 13 at Suburban Hospital in Bethesda. He had chronic lymphocytic leukemia.]]></description>  
             <pubDate>Mon Mar 01 23:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://biz.yahoo.com/prnews/100225/la61098.html]]></guid>  
             <title><![CDATA[Genoptix Announces National Three-Year Agreement With Aetna]]></title>  
             <link><![CDATA[http://biz.yahoo.com/prnews/100225/la61098.html]]></link>  
             <description><![CDATA[[PR Newswire] Genoptix, Inc. today announced that it will participate in Aetna's national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.]]></description>  
             <pubDate>Thu Feb 25 15:05:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feeds.latimes.com/~r/latimes/sports/baseball/mlb/angels/~3/Nl9mICOM8Ak/la-sp-simers23-2010feb23,0,3257373.column]]></guid>  
             <title><![CDATA[        T.J. Simers: Rod Carew, the great hitter, is going to bat for others]]></title>  
             <link><![CDATA[http://feeds.latimes.com/~r/latimes/sports/baseball/mlb/angels/~3/Nl9mICOM8Ak/la-sp-simers23-2010feb23,0,3257373.column]]></link>  
             <description><![CDATA[[Los Angeles Times] Fourteen years after losing his daughter to leukemia, the Hall of Fame member raises funds for pediatric cancer research. Explaining his transition from standoffish to obliging, he says: 'I grew up.'                          It was just another promotional news conference, this one for an All-Star game in Angel Stadium months from now, maybe three or four media types showing up.]]></description>  
             <pubDate>Tue Feb 23 02:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feeds.washingtonpost.com/click.phdo]]></guid>  
             <title><![CDATA[Psychiatrist Robert Litman dies; co-founded suicide prevention center]]></title>  
             <link><![CDATA[http://feeds.washingtonpost.com/click.phdo]]></link>  
             <description><![CDATA[[The Washington Post] Robert E. Litman, 88, a psychiatrist who co-founded the nation's first comprehensive suicide prevention center more than 50 years ago in Los Angeles and carried out groundbreaking work there, died Feb. 14 of acute leukemia in Manhattan Beach, Calif.]]></description>  
             <pubDate>Sat Mar 13 23:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://mnt.to/f/3yVP]]></guid>  
             <title><![CDATA[Risk Stratification Imperative To Treatment Selection In Patients With AML]]></title>  
             <link><![CDATA[http://mnt.to/f/3yVP]]></link>  
             <description><![CDATA[[Medical News Today, UK] Using risk stratification to assist in treatment selection was just one of the focal points at a recent presentation of the NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines') for Acute Myeloid Leukemia (AML) at the NCCN 15th Annual Conference. B...]]></description>  
             <pubDate>Mon Mar 15 06:00:00 CDT 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feedproxy.google.com/~r/mnt/healthnews/~3/Sr4s-RyfHKY/3yhq]]></guid>  
             <title><![CDATA[Clinical Trial Participation Alone May Not Be Associated With Improved Outcomes For Childhood Cancer Patients]]></title>  
             <link><![CDATA[http://feedproxy.google.com/~r/mnt/healthnews/~3/Sr4s-RyfHKY/3yhq]]></link>  
             <description><![CDATA[[Medical News Today, UK] Children with the most common childhood cancer did not experience improved outcomes from participating in a clinical trial between 1997 and 2005. Carl Koschmann, M.D., and colleagues at the University of Washington and Seattle Children's Hospital studied 322 patients with newly diagnosed acute lymphoblastic leukemia (a cancer involving the white blood cells), approximately half of whom participated in one of several available clinical trial protocols for the disease...]]></description>  
             <pubDate>Mon Mar 01 17:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feedproxy.google.com/~r/mnt/healthnews/~3/Xw3ZtCNsHGg/3yfw]]></guid>  
             <title><![CDATA[Vion Pharmaceuticals Receives Response From FDA On Special Protocol Assessment For Onrigin(TM)]]></title>  
             <link><![CDATA[http://feedproxy.google.com/~r/mnt/healthnews/~3/Xw3ZtCNsHGg/3yfw]]></link>  
             <description><![CDATA[[Medical News Today, UK] VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VIONQ) announced that it had received a response from the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment ("SPA") for its oncology therapeutic Onrigin' (laromustine) Injection. In January 2010, Vion filed a SPA with the FDA related to a randomized Phase II/III trial of Onrigin' in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML)...]]></description>  
             <pubDate>Sat Feb 27 04:00:00 CST 2010</pubDate>  
      </item>  
       <item>  
             <guid isPermaLink="true">  <![CDATA[http://feedproxy.google.com/~r/mnt/healthnews/~3/q865y3hJc_Q/3yn5]]></guid>  
             <title><![CDATA[U.S. Food And Drug Administration (FDA) Sets 22 March For Oncologic Drugs Advisory Committee (ODAC) Meeting To Review OMAPRO']]></title>  
             <link><![CDATA[http://feedproxy.google.com/~r/mnt/healthnews/~3/q865y3hJc_Q/3yn5]]></link>  
             <description><![CDATA[[Medical News Today, UK] ChemGenex Pharmaceuticals Limited (ASX:CXS) announced that the U.S. Food and Drug Administration (FDA) has rescheduled the previously postponed Oncologic Drugs Advisory Committee (ODAC) meeting to 22 March 2010.  The ODAC meeting will consider ChemGenex's application for OMAPRO' (omacetaxine mepesuccinate) for the treatment of adults with chronic myeloid leukemia (CML) who have failed prior therapy with imatinib and who have developed the Bcr-Abl T315I mutation...]]></description>  
             <pubDate>Wed Mar 03 03:00:00 CST 2010</pubDate>  
      </item>  
       </channel>  
</rss>  
